Skip to content

Tyra Biosciences, Inc. TYRA Other Income (Expense)

Other Income (Expense) at other companies

Incyte logo
IncyteINCY
$2.77M-65.7%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-$60.6M+7.1%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
-$8.47M-678%
Nuvation Bio logo
Nuvation BioNUVB
$1.52M-73.7%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$6M-40.0%
BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN

Other financials

Income statement

See full
Operating income-$42.0M-31.9%
Net income-$39.3M-39.6%
EPS (diluted)-$0.64-36.2%

Balance sheet

See full
Cash & equivalents$85.0M-15.7%
Total debt$5.7M-6.9%
Total equity$387.6M+19.8%
Total assets$412.0M+20.0%

Cash flow

See full
Operating cash flow-$32.6M-27.9%
CapEx$88.0K+529%
Free cash flow-$32.7M-28.2%

Valuation

See full
Market cap$1.81B+318%
Enterprise value$1.73B+397%

Returns & leverage

See full
Return on equity-36.9%+21.1pp
Debt / equity0.0×
Current ratio20.5×-2.3×

Where this comes from

Reported directly by Tyra Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The official record: Tyra Biosciences, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tyra Biosciences, Inc.'s other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tyra Biosciences, Inc.'s other income (expense)?
Tyra Biosciences, Inc. (TYRA) reported other income (expense) of $2.69M in Q1 2026.
How has Tyra Biosciences, Inc.'s other income (expense) changed year-over-year?
Tyra Biosciences, Inc.'s other income (expense) decreased by 27.3% year-over-year, from $3.7M to $2.69M.
What is the long-term trend for Tyra Biosciences, Inc.'s other income (expense)?
Over 3 years (2022 to 2025), Tyra Biosciences, Inc.'s other income (expense) has grown at a 52.7% compound annual growth rate (CAGR), from $3.6M to $12.82M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.